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Summary 
Mice deficient in inducible nitric oxide synthase (INOS) 
were generated to test the idea that iNOS defends the 
host against infectious agents and tumor cells at 
the risk of contributing to tissue damage and shock. 
INOS- mice failed to restrain the replication of Listeria 
monocytogenes in vivo or lymphoma cells in vltro. 
Bacterial endotoxlc lipopolysaccharide (LPS) caused 
shock and death in anesthetized wild-type mice, but 
in iNOS-I- mice, the fall In central arterial blood pres- 
sure was markedly attenuated and early death averted. 
However, unanesthetized INOW- mice suffered as 
much LPS-induced liver damage as wild type, and 
when primed with Proplonobacterium acnes and chal- 
lenged with LPS, they succumbed at the same rate as 
wild type. Thus, there exist both iNOS-dependent and 
iNOS-independent routes to LPS-induced hypoten- 
sion and death. 
Introduction 
Nitric oxide (NO) participates in the physiologic and patho- 
physiologic regulation of every mammalian organ system 
(Moncada et al., 1991; Nathan and Xie, 1994b). Three 
known NO synthases (NOSs) encoded by distinct genes 
are activated by binding calmodulin, but one of them, 
NOS2, does so without requiring an agonist-induced ele- 
vation of the intracellular Caz+ concentration (Nathan and 
Xie, 1994b). Instead, the chief means of activation of 
NOS2 is its transcriptional induction by cytokines and mi- 
crobial products (Xie et al., 1992). The independence of 
NOS2 from reliance on elevated Ca*+ led to the designa- 
tion iNOS (Xie et al., 1992) and confers the capacity for 
sustained production of NO. High-output NO production 
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by macrophages, hepatocytes, chondrocytes, endothelial 
cells, fibroblasts, smooth myocytes, cardiac myocytes, 
and other cells appears to restrict the replication of hel- 
minths, protozoa, bacteria, viruses, and tumor cells at the 
potential cost of inflammatory damage to host cells and 
tissues (Hibbs et al., 1987; Stuehr and Nathan, 1989; Na- 
than and Hibbs, 1991; Karupiah et al., 1993; Nathan and 
Xie, 1994a, 1994b). 
Functions unique to iNOS have not been adequately 
defined with pharmacologic inhibitors. To varying de- 
grees, inhibitors of iNOS activity also affect NOSl (consti- 
tutively expressed in neurons, skeletal muscle, renal mes- 
angial cells, and pancreatic islets) and NOS3 (constitutive 
in endothelium, neurons, and epithelial cells) and, like all 
drugs, do or may have side effects. Further, the diversity 
of the molecular origins, targets, and actions of NO makes 
it difficult to anticipate the consequences of inhibiting its 
production in disease. Animals genetically deficient in 
NOSs bypass these issues; mice lacking NOSl or NOS3 
have been generated (Huang et al., 1993; P. Huang, 
personal communication). Herein are described mice 
(INOW) whose NOS2 gene has been inactivated through 
homologous recombination. These mice allowed us to test 
the concept that iNOS is a two-edged sword, an enzyme 
that defends the host against infection, but at substantial 
risk. 
Results 
Generation of iNOS-Deficient Mice 
Overlapping cosmid clones were isolated comprising a 72 
kb mouse genomic contig that contained -38 kb of the 
NOS2 locus plus 38 kb of upstream sequences. The gene 
replacement vector plNOS-RVl was designed to delete 
the proximal 585 bases of the iNOS promoter, a region 
required for iNOS expression in macrophages (Xie et al., 
1993) plus exons 1-4, including the ATG translational 
start site in exon 2 (Figure 1 A). The targeting vector was 
electroporated into mouse embryonic stem (ES) cells. Two 
karyotypically normal targeted clones were isolated at fre- 
quencies of 1:937 with coelectroporation of herpes sim- 
plexvirusthymidine kinase(HSV-fk)and - 1:4000without 
HSV-tk(Figures 1 B-l D). Only the latter clone gave germ- 
line transmission from coat color chimeric mice generated 
by blastocyst injection. From these we derived viable, ho- 
mozygous knockout mice (Figure 1 E). 
Southern blot hybridization analysis of wild-type mice 
using iNOS cDNA fragments as probes, including the re- 
gion described as duplicated in rat based on reverse tran- 
scription polymerase chain reaction (PCR) (Mohaupt et 
al., 1994) detected only single hybridizing genomic frag- 
ments in the mouse, and these mapped to the NOS2 allele 
contained in the overlapping cosmids of Figure 1A. In 
INOS-‘- mice, Southern blot hybridization was negative 
with sequences from exons 1, 2, and 4 (data not shown). 
Thus, mice have only one NOS2 allele, and in INOW 
mice its, 5’ sequences are deleted. 
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Extent and Selectivity of iNOS Deficiency 
The extent and selectivity of iNOS deficiency in vivo were 
evaluated by organ Northern blots. After wild-type mice 
were injected with endotoxic bacterial lipopolysaccharide 
(LPS), their hearts, kidneys, lungs, and spleens contained 
iNOS mRNA, but none was detected in INOS? mice using 
acDNAprobeforexons2-8(Figure2). Incontrast, mRNAs 
forNOS7 (in brain) and NOS3 (in most organs) were neither 
diminished along with nor increased in compensation for 
iNOS deficiency (Figure 2). Expression of NOS3 de- 
creased in heart following injection of LPS, similar to ob- 
servations with endothelial cells in vitro (Nishida et al., 
1992; MacNaul and Hutchinson, 1993). NOS3 mRNA in 
heart from untreated mice cross-hybridized faintly with 
iNOS probes (nucleotides 200-l 017 and 15952468) (Fig- 
ure 2; data not shown). 
At the cellular level, the analysis focused on peritoneal 
macrophages, in which mammalian production of inor- 
ganic oxides of nitrogen was initially demonstrated in vitro 
(Stuehr and Marletta, 1985), in which a function of NO 
production was discerned (Hibbs et al., 1987) and from 
which iNOS was purified (Stuehr et al., 1991) and cloned 
(Lyons et al., 1992; Xie et al., 1992; Lowenstein et al., 
1992). Peritoneal macrophages of iNOSY mice lacked 
iNOS mRNA (Figure 3A), protein (Figure 38), and enzyme 
activity (Figure 3C) with every inductive regimen tested 
that led to iNOS expression in wild-type mice. Thus, mac- 
rophages from INOS- mice were deficient in producing 
NO not only in response to the combination of interferon-y 
(IFNy) plus LPS, but also with an inductive regimen that 
was independent of IFNy (namely, lFNa@ plus LPS), even 
though the primary IFNy response element in the NOS2 
promoter, IRF-E (Kamijo et al., 1994; Martin et al., 1994), 
was not deleted. Likewise, these cells were deficient in 
producing NO in response to inductive regimens indepen- 
dent of LPS (namely, IFNr alone or together with tumor 
necrosis factor a [TNFa]). 
The respiratory burst of activated macrophages closely 
Figure 1. Targeted Disruption of the Murine 
NOS2 Gene 
(A) Map of the 5’ end of NOS2 locus and the 
targeting vector plNOS-RVI . Closed boxes de- 
note exons l-8. Location of exon 6 (stippled 
box) is approximate. Exon 2 contains the trans- 
lation start site ATG. Restriction enzyme abbre- 
viations: Ap, Apal; B, BarnHI; E, EcoRI; H, 
Hindlll; Hn, Hincll; K, Kpnl:, Nh, Nhel; P, Pstl; 
Xb, Xbal; X, Xhol. Open box indicates position 
of the 5’ Kpnl-EcoRI probe used for Southern 
blot hybridization in (C)-(E); arrows mark diag- 
nostic Kpnl fragments. 
(B) Predicted map of the disrupted allele. 
(C) Expected sizes for Apal, Kpnl, and Pstl re- 
striction fragments. 
(D) Southern blot hybridization analysis of ge- 
nomic DNA from control ES cells (129/Sv ES 
cell line D3) and NOSZ-targeted clones 6.76 
and 5.23.733. 
(E) Southern blot hybridization of Kpnl- 
digested genomic DNA from tail biopsies of Fl 
intercross progeny. 
resembles the high-output NO pathway in that it is a major 
IFNr-enhanced antimicrobial mechanism that consists of 
NADPH-, 02-, FAD-, and cytochrome-dependent genera- 
tion of a cytotoxic, inorganic radical gas(superoxide). Mac- 
rophages from iNO!%‘- mice activated in vivo with IFNy 
plus LPS preserved their respiratory burst capacity. This 
was assessed by release of the dismutation product of 
superoxide, HZ02, following triggering by phorbol myris- 
tate acetate, bacillus Calmette-GWin, or Listeria monocy- 
togenes (Figure 3D). The modest increase in respiratory 
burst of macrophages from INOW- compared with wild- 
type mice is consistent with the enhancement in H202 re- 
lease from wild-type macrophages seen with a NOS inhibi- 
tor (Ding et al., 1988) and suggests that NO may normally 
damage the respiratory burst oxidase (Clancy et al., 1992), 
compete for NADPH, or react with some of the superoxide, 
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Figure 2. Comparative Expression of NOS lsoforms in Vivo 
(Top) Total RNAs from brain (Bn), heart (Ht), kidney (KY), lung (Lg), 
and spleen (Sn) from mice injected 5.5 hr earlier with saline (S) or 
LPS (L) were probed with an iNOS cDNA fragment (nucleotides 200- 
1017; exons 2-9) and additionally with a rat NOS3 cDNA fragment. 
Blots were stripped and reprobed for glyceraldehyde 3-phosphate de- 
hydrogenase (GPDH). 
(Bottom) Total RNAs from the same organs as above plus liver (Lr) 
from LPS-treated mice were probed with a rat NOS7 cDNA fragment. 
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diverting it to peroxynitrite (Carreras et al., 1994). That 
INOS- macrophages remained directly responsive to 
IFNy was demonstrated by the in vitro induction of major 
histocompatibility complex (MHC) class II antigen expres- 
sion (Figure 3E). 
Phenotype of Uninfected iNOS-Deficient Mice 
Under specific pathogen-free conditions, iNOW mice 
survived weaning at the expected Mendelian ratio: geno- 
typing of 353 F2 mice, as shown in Figure lE, revealed 
26% knockout, 26% wild-type, and 48% heterozygous an- 
imals. From 4-l 1 weeks of life, INOS- mice weighed the 
same as wild type and gained weight at the same rate 
(data not shown). Mature INOW mice produced litters at 
a normal frequency and size. 
The following tissues were examined grossly and micro- 
scopically in six INOW- mice (three males) and four wild- 
type mice (two males) aged 9-10 weeks in the F2 gen- 
eration (129/SvEv x C57BU8) and were found to be 
histologically normal: brain, pituitary, spinal cord, periph- 
eral nerve, eye, Harderian gland, nose, tongue, salivary 
gland, thyroid, parathyroid, heart, aorta, lung, thymus, 
lymph node, skeletal muscle, skin, mammary gland, stom- 
ach, small and large intestine, liver, gall bladder, pan- 
creas, spleen, adrenal, kidney, urinary bladder, uterus, 
ovaries, vagina, brown fat, bone/joints, and bone marrow. 
In the same mice, the following were normal: erythrocyte 
Figure 3. Selective Inability of iNO!?/- Macro- 
phages to Express iNOS mRNA, Protein, or 
Enzyme Activity 
(A) Northern blot analysis. Total RNAfrom thio- 
glycollate broth-elicited peritoneal exudate 
macrophages unstimulated (U) or activated (I) 
in vitro for 20 hr with LPS and rMulFNy was 
probed for iNOS and GPDH. wt, wild type. 
(6) Western blot analysis. Peritoneal exudate 
macrophages from INOSY (lanes 1 and 2) or 
wild-type (lanes 3 and 4) mice were activated 
in vitro without (lanes 1 and 3) or with (lanes 
2 and 4) LPS and rMulFNr and their lysates 
immunoblotted with rabbit anti-holo-iNOS IgG. 
(C) NO generation. Thioglycollate broth-elic- 
ited macrophages were exposed in vitro for 46 
hr to buffer alone, LPS, rMulFNy, rMuTNFa, 
natural mouse IFNalf3, or some combination of 
these. 
(D) Respiratory burst. H202 release from perito- 
neal macrophages from iNOS (closed sym- 
bols) or wild-type (open symbols) mice acti- 
vated in vivo by intraperitoneal injection of LPS 
plus rMu1FN-r 24 hr before harvest. In vitro, 
cells were untreated (open diamonds) or trig- 
gered with phorbol myristate acetate (open cir- 
cles), bacille Calmette-Guerin (open squares), 
or human serum-coated L. monocytogenes 
(open triangles). Values are means for tripli- 
cates; SEM fall within the symbols. 
(E) IFNT-induced expression of MHC class II anti- 
gen. Thioglycollate broth-elicited peritoneal 
macrophages were incubated 46 hr with or with- 
out rMulFNy and then stained with rat anti- 
mouse MHC class II MAb followed by fluorescein 
isothiocyanate-conjugated goat F(ab3, anti-rat 
IgG for analysis by flow microfluorimetry. 
count, hemoglobin, hematocrit, mean corpuscular vol- 
ume, platelet count, leukocyte count, proportion and mor- 
phology of neutrophils, eosinophils, monocytes and lym- 
phocytes, blood glucose, urea nitrogen, creatinine, total 
protein, albumin, globulin, total bilirubin, alkaline phos- 
phatase, alanine aminotransferase (ALT), aspartate ami- 
notransferase (AST), cholesterol, triglycerides, sodium, 
potassium, chloride, bicarbonate, calcium, phosphorus, 
magnesium, and osmolality. 
Suspensions of thymus and spleen cells from INOW 
and wild-type mice were indistinguishable when analyzed 
by flow microfluorimetry to enumerate lymphocytes posi- 
tive for immunoglobulin, CD3, CD4, CD8, or MHC class 
II antigens. Moreover, inflammatory responses were nor- 
mal in INOS-” mice, in that the same types and numbers 
of leukocytes accumulated in the peritoneal cavity as in 
wild-type mice in response to intraperitoneal injection of 
thioglycollate broth, sodium periodate, or IFNy plus LPS 
(data not shown). 
Host Defense Functions of iNOS 
The INOS- mice were used to test the importance of 
iNOS in host defense against bacteria and tumor cells. L. 
monocytogenes, a gram-positive opportunistic pathogen, 
enters Kupffer cells, hepatocytes, and splenic macro- 
phages, eliciting a neutrophilic followed by a monocytic 
infiltrate (Conlan and North, 1994). Each of these host 
Cdl 
644 
0 10” lo.= 10” 1 10’ to2 10’ 
1FN-y (U/ml) 
Figure 4. Role of iNOS in Host Defense 
(A) Survival after intravenous infection of INOS? (closed symbols) or 
wild-type (open symbols) mice with the indicated inocula of L. monocy- 
togenes. 
(B) Bacterial burden in liver and spleen. INOW (closed symbols) or 
wild-type (open symbols) mice were inoculated intraperitoneally with 
4 x 105 cfu of Listeria and sacrificed 3 days later. Values are means 
for individual organs; SEM fall within the symbols. Horizontal bars 
show group means. 
(C) Restriction of tumor cell growth. Thioglycollate broth-elicited peri- 
toneal exudate macrophages from iNO.%- (closed symbols) or wild- 
type (open symbols) mice were exposed to LPS (10 @ml) and the 
indicated concentrations of rMulFNT at the same time as they were 
admixed with lymphoma cells. Tumor cell proliferation (open squares) 
and NO; plus NO*- (open circles) were measured. Values are means 
f SEM for triplicate experiments. 
cells is capable of expressing iNOS (Xie et al., 1992; Geller 
et al.;1993; Nathan and Xie, 1994a), often under the influ- 
ence of IFNy produced by natural killer cells and antigen- 
specific T cells, and IFNy confers antilisterial activity (Far- 
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rar and Schreiber, 1993). Studies with NOS inhibitors have 
been conflicting, suggesting both that iNOS is protective 
in listeriosis, perhaps because it is bacteriostatic (Becker- 
man et al., 1993; Boockvar et al., 1994) and that iNOS 
is counterproductive, possibly because it suppresses T 
cells (Gregory et al., 1993). Mice deficient in iNOS suc- 
cumbed to inocula of Listeria at least lo-fold lower than 
those lethal to wild-type mice (Figure 4A), in association 
with - lOO-fold greater bacterial burdens in liver and 
spleen (Figure4B). Likewise, activated macrophagesfrom 
INOSY mice failed to restrict the replication of lymphoma 
cells in vitro (Figure 4C), confirming the interpretation of 
pharmacologic evidence for the importance of NO in the 
same system (Stuehr and Nathan, 1989). 
Role of iNOS in Septic Shock 
The role of iNOS in septic shock is controversial. Accord- 
ingly, we wished to measure both arterial blood pressure 
and survival in INOSY and wild-type mice. Given the in- 
creased susceptibility of iNOS+ mice to some bacterial 
infections, demonstrated above, we used models of septic 
shock that did not involve injection of live bacteria. 
To measure blood pressure, mice were anesthetized 
and a carotid artery cannulated. Wild-type mice injected 
with LPS (1 mglkg) experienced a progressive, severe 
drop in arterial pressure. By 3.5 hr, the decline averaged 
64% (Figure 5); shortly thereafter, all wild-type mice had 
expired. When mice were given normal saline in place of 
LPS, arterial pressure remained stable for the 5 hr period 
of observation. In contrast, LPS-treated INOSY mice all 
survived the experiment; their blood pressure fell only 
15% by 2 hr and thereafter was stable. The LPS-induced 
hypotensive response of heterozygotes (iNOS+‘-) was in- 
termediate between that of wild-type and iNO!?- mice. 
All survived; by 5 hr, however, their blood pressure had 
declined 30% (Figure 5). Heart rate, monitored from the 
electrocardiogram, was not altered in any treatment 
group. 
Unanesthetized wild-type mice injected with LPS (10 
mglkg) accumulated high serum levels of nitrate plus ni- 
Figure 5. Role of iNOS in Endotoxic Shock 
INOS mice (closed symbols), wild-type mice 
(open symbols), or iNOS+‘- heterozygotes 
(symbols with central dot) were matched in 
each experiment for gender and age (8-12 
weeks). Changes in mean arterial blood pres- 
sure (MAP) (means f SEM) were monitored 
for 5 hr or until death following the intraperi- 
toneal injection of saline (circles) or LPS 
(squares). Baseline blood pressure averaged 
61 f 3,70 f 4, and 53 f 4 mm Hg and basal 
heart rate 431 f 35,528 + 42, and 320 f 20 
beatslmin in seven INOW mice (three given 
saline; four given LPS), seven iNOS+‘- hetero- 
zygotes (three given saline; four given LPS), 
and six wild-type mice (two given saline; four 
given LPS), respectively. 
!--~ --I T ----I - -  
0 50 100 150 200 250 300 
Time (men) 
Mice Deficient in inducible Nitric Oxide Synthase 
645 
trite (Figure 6A) and lactate dehydrogenase (LDH), ALT, 
and AST (Figure 6B). Elevation in the serum enzymes 
indicated damage to hepatocytes. In iNO.%- mice, LPS 
caused no increase in serum nitrate (Figure 6A). Nonethe- 
less, levels of LDH, ALT, and AST were elevated (Figure 
6B), as in LPS-injected wild-type mice treated with a NOS 
inhibitor (Harbrecht et al., 1994). Serum cytokines were 
measured in LPS challenged mice both without (data not 
shown) and with (Figure 6C) an ongoing inflammatory re- 
sponse engendered by prior injection of heat-killed Propio- 
nobacterium acnes, a granuloma-forming bacterium. Lev- 
els of interleukin-1 a (IL-la) (data not shown), IL-16, TNFa, 
and IL-6 were similar in both genotypes (Figure 6C). 
Unanesthetized wild-type mice of the strain in which 
most knockouts have been generated (129/SvEv x 
C57BU6) are relatively resistant to the lethal action of LPS 
as a sole agent; their LPS responses are usually tested 
after sensitization by prior injection of bacteria, carra- 
geenan, or the hepatotoxin D-galactosamine (Pfeffer et 
al., 1993; Rothe et al., 1993; Kamijo et al., 1993; Xu et 
al., 1994). We tested survival of unanesthetized, uninstru- 
mented mice both without (Figure 7A) and with (Figure 
7B) prior injection with heat-killed P. acnes. In untreated 
mice (Figure 7A), iNOS deficiency conferred partial resis- 
tance to lethality induced by high-dose LPS (30 mglkg), 
although not at the lower doses tested. In contrast, in the 
Figure 6. Serum Markers in LPS-Challenged Mice 
(A) N03- plus N02- in sera of 11 mice per group injected with saline 
or LPS and sacrificed 5.5 hr later or in six mice per group injected 
with heat-killed P. acnes followed 6 days later by LPS. Sera were 
collected from the latter mice after they died naturally 9-10.5 hr after 
administration of LPS. 
(B) ALT, AST, and LDH (see text) activities in the sera of the mice in 
(A) not given P. acnes. 
(C) Levels of IL-1 6, TNFa, and IL-6 determined by ELISA in plasma 
of iNOW mice (closed symbols) and wild-type mice (open symbols) 
(circles for females; squares for males) injected with heat-killed P. 
acnes(l mg)followed6dayslaterby LPS(lOOpg). Bloodwascollected 
0,90, or 160 min after injection of LPS. Results for IL-1 a closely resem- 
bled those for IL-1 6. 
context of P. acnes-induced inflammation, LPS-treated 
INOS- mice died at the same rate as wild type (Figure 
7B), without the increase of the latter in serum nitrate (see 
Figure 6A). 
Necropsies of three INOS-” and two wild-type mice that 
died after LPS administration revealed pyogranulomata 
infiltrating liver, lymph nodes, and mesentery, consistent 
with injection of heat-killed P. acnes 6 days earlier. The 
acute changes attributable to endotoxemia were marked 
margination of leukocytes, primarily polymorphonuclear 
cells, along the endothelia of arteries, veins, arterioles, 
venules, and capillaries, especially in lung and liver; multi- 
focal hepatocellular necrosis and hepatic endothelial cell 
injury; and disseminated intravascular coagulation. The 
histopathology in wild-type and INOS- mice was indistin- 
guishable (data not shown). 
Protean roles ascribed to iNOS include participation in the 
dilatation of the gravid uterus, with rapid disappearance 
of the enzyme marking the onset of parturition (Sladek et 
al., 1993; Yallampalli et al., 1994). Thus, it was doubtful 
whether mice lacking iNOS could bring pregnancies to 
term, just as the role of NOSl in penile erection (Rajfer 
et al., 1992; Burnett et al., 1992) raised the possibility that 
NOSV mice would fail to reproduce. However, as for 
NOSl (Huang et al., 1993) the generation of enzyme- 
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Figure 7. Survival of Unanesthetized Mice Challenged with LPS 
(A) Mice were injected with the indicated doses of LPS. (8) Mice were 
injected with saline or heat-killed P. acnes followed 6 days later by 
vehicle alone or vehicle containing the indicated doses of LPS. In 
both panels, open symbols denote wild-type mice and closed symbols, 
INOW mice. 
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deficient mice by homologous recombination has proved 
that iNOS is dispensable in the development and repro- 
duction of the mouse. 
The normality of uninfected INOS- mice extended to 
the accumulation of leukocytes in the irritated peritoneal 
cavity; the formation of granulomas in the bacteria-laden 
liver, spleen, lymph nodes, and mesentery; and the mar- 
gination of neutrophils in the LPS-challenged lung. These 
normal inflammatory responses were surprising, given evi- 
dence implicating iNOS in leukocyte adhesion, migration, 
and accumulation (Mulligan et al., 1991; Belenky et al., 
1993). Nor did iNOS appear to block the production of 
inflammatory cytokines in endotoxin-treated mice, as it 
was inferred to do in mice provoked with enterotoxin (Flor- 
quin et al., 1994). 
Studies in INOS-‘- mice strongly supported the role of 
iNOS in host defense against Listeria in vivo and lymphoma 
in vitro. Macrophages from NF-ILG-deficient mice resembled 
those from iNOSY mice in their poor antibacterial and anti- 
tumor activity (Tanaka et al., 1995). NF-ILG-‘- macro- 
phages expressed iNOS normally, yet the cytotoxic activi- 
ties of wild-type macrophages in the same assays were 
NOdependent. Tanakaet al. (1995)concluded that macro- 
phage-mediated cytotoxicity requires two different mecha- 
nisms, one unidentified but depending on NF-IL6, the 
other involving iNOS. Our results are consistent with this 
formulation. Many other models of infectious and malig- 
nant disease deserve to be tested in iNOS deficiency. 
Given the redundancy of host defense systems and the 
diverse countermechanisms of pathogens, it can be antici- 
pated that the relative role of iNOS will range from minimal 
to critical. 
The most controversial issue addressed through the use 
of INOS-‘- mice is the pathogenesis of septic shock. This 
complex syndrome, the leading cause of death in intensive 
care units, claims >lOO,OOO lives per year in the United 
States alone (Parrillo, 1993; Natanson et al., 1994). Septic 
shock is a systemic inflammatory process that erupts 
when LPS or other microbial products trigger production 
of TNF, IL-l, IL-12, IFNr, leukemia inhibitory factor, migra- 
tion inhibitory factor, platelet-activating factor, eicosa- 
noids, and products of the complement and clotting cas- 
cades (Beutler et al., 1985; Taylor et al., 1967; Ohlsson 
et al., 1990; Bone, 1992; Kohler et al., 1993; Block et al., 
1993; Creasey et al., 1993; Pfeffer et al., 1993; Rothe et 
al., 1993; Kamijo et al., 1993; Bernhagen et al., 1993; Xu 
et al., 1994). On the presumed final common path todeath, 
central blood pressure falls and becomes refractory to 
pressors, blood flow maldistributes, the myocardium is de- 
pressed, tissues extract oxygen poorly, and organs fail. 
NO can lower blood pressure (Moncada et al., 1991), 
block response to pressors (Thiemermann, 1994) influ- 
ence the distribution of the circulation (Moncada et al., 
1991) suppress cardiac myocytes (Roberts et al., 1992; 
Finkel et al., 1992; Balligand et al., 1993) and interfere 
with cellular respiration (Stuehr and Nathan, 1969; Hibbs 
et al., 1990). NO is produced in large amounts during infec- 
tion (Stuehr and Marletta, 1967; Granger et al., 1991; 
Ochoa et al., 1991; Lai and Komarov, 1994). Infection and 
LPS induce iNOS (Xie et al., 1992; Lowenstein et al., 1992; 
Evans et al., 1993; Thiemermann, 1994), but LPS can also 
activate constitutively expressed NOSs (Salvemini et al., 
1990; Finkel et al., 1992; Thiemermann, 1994) and it is 
not known which NOS(s) generates the excess NO. NOS 
inhibitors reversed hypotension in septic patients (Petros 
et al., 1991, 1994; Schilling et al., 1993; Lorente et al., 
1993) and in dogs and rats given LPS or TNF (Kilbourn 
et al., 1990a, 1990b; Thiemermann and Vane, 1990) and 
improved survival in infected or LPS-treated mice (Teale 
and Atkinson, 1992; Szabo et al., 1994). However, in other 
studies, such drugs worsened outcome (Nava et al., 1991; 
Harbrecht et al., 1992; Cobb et al., 1992; Minnard et al., 
1994; Florquin et al., 1994; Pastor et al., 1994) perhaps 
by blocking the ability of endothelium to generate NO 
needed to forestall thrombosis and dilate small vessels 
perfusing vital organs (Harbrecht et al., 1992). Thus, it has 
been proposed that iNOS sits astride the final common 
path to death in septic shock. The implication for therapy 
is that the septic host might be helped by an inhibitor that 
targets iNOS but spares NOS3 in endothelium. The advent 
of iNOW mice afforded the opportunity to test the validity 
of this concept. 
A major finding of this study was that anesthetized mice 
deficient in iNOS were substantially protected from cardio- 
vascular collapse induced by LPS, a cardinal feature of 
septic shock, and survived for the duration of the experi- 
ment. In contrast, wild-type mice became profoundly hypo- 
tensive and died. Heterozygotes (iNOS+‘-) had an inter- 
mediate degree of LPS-induced hypotension, and, like 
iNOW mice, they survived. The gene-dosage effect im- 
plies that pharmacologic inhibitors specific for iNOS might 
provide a clinically significant degree of protection against 
LPS-induced hypotension even if they did not inhibit iNOS 
completely. At the same time, INOW mice provided proof 
not based on pharmacologic agents that there exist other, 
quantitatively less important but still significant contribu- 
tor(s) to LPS-induced hypotension. The possible relevance 
of these findings to septic shock in humans is not readily 
dismissed. Blood nitrate was high in septic patients 
(Ochoa et al., 1991) and at least 15 types of human cells 
can express INOS, including vascular smooth muscle 
cells, cardiac myocytes, hepatocytes, and macrophages 
(Nathan and Xie, 1994b). 
Like anesthetized mice, conscious mice that were other- 
wise untreated appear to be protected by iNOS deficiency 
from death associated with high-dose LPS. Nonetheless, 
INOW mice injected with LPS had the same biochemical 
evidence of liver damage as wild type, and iNOW mice 
primed with P. acnes and then challenged with LPS died 
as quickly as wild type. The latter model may approach 
clinical relevance insofar as it mimics localized, indolent, 
or partially controlled infections from which microbes or 
their products spill abruptly into the blood. The vulnerabil- 
ity of iNOS-‘- mice in this setting suggests that there may 
be redundant routes to endotoxic death. 
In animals, numerous candidate mediators of septic 
shock have been neutralized prophylactically by injection 
of inhibitors or generation of mice deficient in the media- 
tors or their receptors (Beutler et al., 1965; Taylor et al., 
1987; Ohlsson et al., 1990; Bone, 1992; Kohleretal., 1993; 
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Blocket al., 1993; Creaseyet al., 1993; Pfeffer et al., 1993; 
Rothe et al., 1993; Kamijo et al., 1993; Bernhagen et al., 
1993; Xu et al., 1994). Leaving aside differences in experi- 
mental models, the efficacy of all these interventions 
tested singly suggests that early on, each such factor is 
necessary and none sufficient for endotoxic or septic 
death. These findings led to extensive clinical testing of 
single agents designed to neutralize either LPS itself or 
one of its mediators (TNFa or IL-l). Such trials have not yet 
been successful. Their outcome was foretold by studies in 
experimental animals in which, once shock had begun, 
no such intervention consistently reversed it. Indeed, phar- 
macologic inhibition of NOS has been one of the very few 
interventions to restore blood pressure when endotoxic or 
septic shock was underway. The lethality of LPS in P. 
acnes-primed iNOW mice underscores that salvage 
fromongoingsepticshockmayrequiresimultaneousinter- 
ruption of more than one final common path, each being 
sufficient and none necessary for death of the host. In this 
view, the paradigm shifts as the syndrome unfolds. 
How did LPS kill INOW mice, if not by making them 
severely hypotensive? Necropsy evidence directs atten- 
tion to iNOS-independent mechanisms of hepatotoxicity 
and neutrophil-mediated endothelial injury. iNOS-inde- 
pendent causes of LPS-induced lethality may be amena- 
ble to analysis in INOW mice and in mice deficient in 
other candidate mediator systems with which INOS- mice 
are interbred. Likewise, backcrossing of iNOS deficiency 
to disease-susceptible backgrounds will allow investiga- 
tion of the role of iNOS in other inflammatory states. 
Experimental Procedures 
Studies at each institution are performed according to its guidelines 
for animal use and care. 
Generation of iNOS-Deficient Mice 
A cosmid library was constructed using Jl ES cell genomic DNA as 
described elsewhere (Mudgett and Maclnnes, 1990) from which over- 
lapping cosmid clones were isolated using a probe from iNOS cDNA 
(Flinch-EcoRI) containing exons 2-8. Only one genomic locus was 
isolated. This genomic contig contained the 5’ 36 kb of mouse NO.82 
(- 75% of the coding region) and contributed toconstructionof plNOS- 
WI as follows. A 5’ 1034 bp arm was subcloned from a murine iNOS 
promoter fragment (Xie et al., 1993) isolated from the same ES cell 
library. A r-red marker gene driven by the PGK promoter (PGK-neo) 
was inserted in the antisenseorientation, and a3’6.7 kb arm containing 
exon 5 and downstream sequences was subcloned from a cosmid and 
inserted. AB2.1 ES cells (4 x 1 OS) maintained as described elsewhere 
(Mudgett and Livelli, 1995) were electroporated in buffer (Specialty 
Media) with 5 ug of linearized plNOS-RVl with or without a 6-fold molar 
excess of nonlinearized vector containing the HSV-f/r gene driven by 
the PGK promoter. Transformants were selected in 200 kg/ml genet- 
icin (GIBCO BRL) and 0.2 uM FIAU as single clones in 100 mm diame- 
ter platesor in poolsof 15-25 clones in 13 mm diameterwells. Cotrans- 
fection with PGK-f/r yielded an -3-fold enrichment. Genomic DNAs 
from clones or pools were isolated and screened by PCR using a 5’ 
primer flanking the NOS2 gene (5”GAGCAATGTGACAAAGCTCCTT- 
CAGACTAGG-3’) and a 3’ primer specific to the PGK-neo marker (5’- 
GCCTGAAGAACGAGATCAGCAGCCTCTG-3’). PCR-positive clones 
(6.76, isolated as a single clone; 5.23.133, isolated from a pool) were 
shown by Southern blot hybridization to have a targeted iNOS allele. 
Northern and Western Slot Hybridizations 
Total RNA was prepared from organs of two or three mice of each 
genotype, matched for age and gender, 5.5 hr following injection of 
saline or LPS (10 mg/kg), and from thioglycollate broth-elicited perito- 
neal exudate macrophages that had been left unstimulated or had 
been activated in vitro for 20 hr with LPS (100 nglml; from Escherichia 
coli OllB4; Sigma) and recombinant murine INFr (rMulFNy) (50 U/ml; 
Genzyme). The RNA (5 ug) was separated on formaldehyde agarose 
gels, bound to Duralon membranes (Stratagene), and probed with a 
“P-labeled cDNA fragment (nucleotides 200-1017) from mouse iNOS 
(Xie et al., 1992). For organ blots, filters were additionally probed with 
a rat NOS3 cDNA fragment from T. Michel (aligns with nucleotides 
2071-2394 of bovine NCJS3 cDNA; Genbank accession number 
U02534) and with a rat NOS7 cDNA fragment (nucleotides 1546-l 942) 
from D. Bredt (Bredt et al., 1991). 
For immunoblots, thioglycollate broth-elicited peritoneal exudate 
macrophages were activated in vitro for 42 hr as described elsewhere 
(Ding et al., 1988) with or without LPS (100 @ml) and rMu1FN-r (50 
U/ml). Lysates (60 ug of protein per lane) were subjected to SDS- 
PAGE, electrophoretic transfer to nitrocellulose, and blotting with rab- 
bit anti-holo-iNOS immunoglobulin G (IgG) asdetailed (Xie et al., 1992). 
Macrophage NO Generation, Resplratory Burst, 
and MHC Class II Expression 
NOS activity was assessed in macrophages elicited as above and 
exposed in vitro for 48 hr to buffer alone, LPS (100 nglml), rMulFNy 
(500 U/ml; Genentech), rMuTNFa (1000 U/ml; Genzyme), natural 
mouse lFNal8 (1000 U/ml; Lee Biomolecular), or some combination 
of these. N03- in the medium was >90% converted to NO,- with asper- 
gillus nitrate reductase (0.05 U/ml; Boehringer) and N03- plus NO*- 
in triplicate cultures quantified by Griess’s assay as detailed elsewhere 
(Ding et al., 1988). 
The respiratory burst was measured by the H20z-dependent oxida- 
tion of fluorescent scopoletin as in Ding et al. (1988) using peritoneal 
macrophages activated in vivo by intraperitoneal injection of LPS (5 
ug) plus rMulFNy (10’ U) 24 hr before harvest. Cells were cultured 
3.5 hr to allow demise of the <4% contaminating neutrophils and then 
either left untreated or triggered with phorbol myristate acetate (100 
rig/ml; Sigma), bacilleCalmette-Guerin (6 x 10Bcfu/ml; Pasteur strain; 
Trudeau Institute), or human serum-coated L. monocytogenes (2 x 
10’ cfulml; clinical isolate; New York Hospital). 
Thioglycollate broth-elicited peritoneal macrophages were incu- 
bated 48 hr with or without rMulFNy (50 U/ml), then stained with rat 
anti-mouse lAb.d monoclonal antibody (MAb) 821.2 (1 pg/ml; Steinman 
et al., 1980) followed by fluorescein isothiocyanate-conjugated goat 
F(ab’k anti-rat IgG (Chemicon International). Cells (10’ in each group) 
were analyzed by flow microfluorimetry (FACScan; Becton Dickinson). 
Llsterla Infection and Tumor Cytostasls 
Mice matched for gender and age (8-10 weeks) were inoculated intra- 
peritoneally with L. monocytogenes (4 x 105 cfu; EGD strain; Trudeau 
Institute) and sacrificed 3 days later, and the number of colony-forming 
units was determined in triplicate lo-fold serial dilutions of homoge- 
nates of liver and spleen (Conlan and North, 1994). 
Thioglycollate broth-elicited peritoneal exudate macrophages (1 x 
1 O5 per well) were exposed to LPS (10 nglml) and the indicated concen- 
trations of rMulFNy at the same time as they were admixed with L1210 
mouse lymphoma cells (5 x 1O’per well). Tumor cell proliferation was 
measured over 12 hr by the incorporation of PH]thym idine as described 
elsewhere (Stuehr and Nathan, 1989) and NOI- plus NO1- was mea- 
sured as above. 
Blood Pressure, Serum Factors, and Survival 
in Endotoxic Shock 
Mice matched in each experiment for gender and age (8-12 weeks) 
were anesthetized with pentobarbital(60 mglkg). Cannulas (30 gauge) 
were placed in the right carotid artery and connected to a pressure 
transducer (Gould). Blood pressure was monitored on aTA4OOOGould 
polygraph for 5 hr or until death following the intraperitoneal injection 
of saline (0.2 ml) or LPS (1 mg/kg in 0.2 ml of saline). The experimenter 
was not blinded, but administered no therapy. 
Levels of NO,- plus NO*- were measured in triplicate by the method 
described above in sera of 11 mice per group injected intravenously 
with 0.2 ml of saline or LPS (10 mglkg in 0.2 ml of saline) and sacrificed 
5.5 hr later or in six mice per group injected intraperitoneally with 
autoclaved P. acnes (1 mg) followed 6 days later by LPS injection 
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intraperitoneally (100 ug). The autoclaved bacteria were shown by 
culture to be nonviable. Sera were collected from the latter mice after 
they died naturally 9-10.5 hr after administration of LPS. 
Levels of IL-la and IL-18 TNFa, and IL-6 were determined by en- 
zyme-linked immunosorbent assay (ELISA) (Fletcher et al., 1995). Se- 
rum ALT, AST, and LDH activities were measured spectrophotometri- 
caky on a Hitachi 911 automated clinical chemistry analyzer. 
Survival studies in unanesthetized mice followed two protocols. 
first, previously untreated mice were injected intraperitoneally with 
0.1 ml of saline or 0.1 ml of saline containing the indicated amounts 
of LPS. Second, 0.1 ml of saline or heat-killed P. acnes (1 mg in 0.1 
ml of saline) was injected intraperitoneally. Mice were injected 6 days 
later with 0.1 ml of vehicle alone (5% normal mouse serum in saline) 
or 0.1 ml of vehicle containing the indicated amounts of LPS. Survival 
was monitored every 2-4 hr over 4 days and daily thereafter. There 
were no deaths after 4 days. 
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